Expected earnings - Editas Medicine Inc.
Source: US Earnings Reports
Editas Medicine Inc. (EDIT) is expected to report $-0.41 for Q2 2025
Editas Medicine Inc.
NASDAQ: EDIT
EDIT Trading
2.45% G/L:
$2.67 Last:
1,085,358 Volume:
$2.61 Open:
EDIT Latest News
March 09, 2026 07:00:00 am
Editas Medicine Announces Fourth Quarter and Full Year 2025 Results and Business Updates
EDIT Stock Data
$174,737,401
95,568,668
0.4%
71
N/A
Biotechnology & Life Sciences
Healthcare
US
Cambridge
